Different patterns of second‐line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study

AIMS: The understanding of second‐line use of glucose‐lowering drugs (GLDs) in the general population with type 2 diabetes (T2D) treatment is important as recent results have shown cardiovascular benefits with sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) and glucagon‐like peptide‐1 receptor a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Endocrinol Diabetes Metab
Main Authors: Persson, Frederik, Bodegard, Johan, Lahtela, Jorma T., Nyström, Thomas, Jørgensen, Marit E., Jensen, Majken Linneman, Gulseth, Hanne L., Thuresson, Marcus, Hoti, Fabian, Nathanson, David, Norhammar, Anna, Birkeland, Kåre I., Eriksson, Johan G., Eriksson, Jan W.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354817/
https://ncbi.nlm.nih.gov/pubmed/30815564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.36
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker